Search
Aspire Biopharma Holdings Inc
ASBPAdd to Watchlist
6.210USD
+0.350+5.97%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.04MMarket Cap
LossP/E TTM
Aspire Biopharma Holdings Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
6.20K
--
EPS(YoY)
-491.27
-707.60%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its current assets were 1.31M, with a year-on-year change of 2762.37.
What are the total assets of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total assets of Aspire Biopharma Holdings Inc were 1.31M, with a year-on-year change of -80.46.
What are the total liabilities of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total liabilities of Aspire Biopharma Holdings Inc were 7.69M, with a year-on-year change of -50.77.
What is the total equity of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total equity of Aspire Biopharma Holdings Inc was -6.38M, with a year-on-year change of 28.37.
What is the net financing of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its net financing of Aspire Biopharma Holdings Inc was 5.92M, with a year-on-year change of 150.52.
What is the Earnings Per Share (EPS) of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -491.27, with a year-on-year change of -707.60.
What is the debt-to-asset ratio of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 394.41, with a year-on-year change of 86.14.
What is the Return on Assets (ROA) of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -610.00, with a year-on-year change of -549.45.
What is the operating profit of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its operating profit was -19.35M, with a year-on-year change of -526.52.